$86.32
1.531.80%
al cierre: -
$86.53
0.210.24%
After hour: 6:18 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Merck & Co informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
oct 30
Estimación de BPA
$2.360
Estimación de ingresos trimestrales
$17.01B
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$63.62B
Analice el historial de beneficios de Merck & Co utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
MRK | Merck & Co | $1.57 | $2.36 | — | — | $16.66B | $17.01B | — | — | 10/30/2025 | |
MRK | Merck & Co | $2.28 | $2.01 | $2.13 | 5.97% | $16.11B | $15.85B | $15.81B | -0.26% | 07/29/2025 | |
MRK | Merck & Co | $2.07 | $2.14 | $2.22 | 3.74% | $15.78B | $15.30B | $15.53B | 1.50% | 04/24/2025 | |
MRK | Merck & Co | $0.03 | $1.68 | $1.72 | 2.38% | $14.63B | $15.51B | $15.62B | 0.74% | 02/04/2025 | |
MRK | Merck & Co | $2.13 | $1.51 | $1.57 | 3.97% | $15.96B | $16.47B | $16.66B | 1.14% | 10/31/2024 | |
MRK | Merck & Co | -$2.06 | $2.15 | $2.28 | 6.05% | $15.04B | $15.84B | $16.11B | 1.72% | 07/30/2024 | |
MRK | Merck & Co | $1.40 | $1.87 | $2.07 | 10.70% | $14.49B | $15.20B | $15.78B | 3.78% | 04/25/2024 | |
MRK | Merck & Co | $1.62 | -$0.11 | $0.03 | 127.27% | $13.83B | $14.50B | $14.63B | 0.91% | 02/01/2024 | |
MRK | Merck & Co | $1.85 | $1.95 | $2.13 | 9.23% | $14.96B | $15.32B | $15.96B | 4.19% | 10/26/2023 | |
MRK | Merck & Co | $1.87 | -$2.17 | -$2.06 | 5.07% | $14.59B | $14.39B | $15.04B | 4.50% | 08/01/2023 | |
MRK | Merck & Co | $2.14 | $1.32 | $1.40 | 6.06% | $15.90B | $13.78B | $14.49B | 5.13% | 04/27/2023 | |
MRK | Merck & Co | $1.80 | $1.54 | $1.62 | 5.19% | $13.52B | $13.67B | $13.83B | 1.17% | 02/02/2023 | |
MRK | Merck & Co | $1.78 | $1.75 | $1.85 | 5.71% | $13.15B | $14.07B | $14.96B | 6.32% | 10/27/2022 | |
MRK | Merck & Co | $1.31 | $1.69 | $1.87 | 10.65% | $11.40B | $13.87B | $14.59B | 5.21% | 07/28/2022 | |
MRK | Merck & Co | $1.40 | $1.83 | $2.14 | 16.94% | $12.08B | $14.68B | $15.90B | 8.32% | 04/28/2022 | |
MRK | Merck & Co | $1.32 | $1.53 | $1.80 | 17.65% | $12.51B | $13.16B | $13.52B | 2.74% | 02/03/2022 | |
MRK | Merck & Co | $1.74 | $1.55 | $1.75 | 12.90% | $12.55B | $12.33B | $13.15B | 6.68% | 10/28/2021 | |
MRK | Merck & Co | $1.37 | $1.44 | $1.31 | -9.03% | $10.87B | $11.54B | $11.40B | -1.20% | 07/29/2021 | |
MRK | Merck & Co | $1.50 | $1.63 | $1.40 | -14.11% | $12.06B | $12.66B | $12.08B | -4.58% | 04/29/2021 | |
MRK | Merck & Co | $1.16 | $1.38 | $1.32 | -4.35% | $11.87B | $12.68B | $12.51B | -1.31% | 02/04/2021 | |
MRK | Merck & Co | $1.51 | $1.43 | $1.74 | 21.68% | $12.40B | $12.17B | $12.55B | 3.13% | 10/27/2020 |
Merck & Co (MRK) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-29 | $2.13 | $2.01 | 5.97 % |
| Q1 | 2025-04-24 | $2.22 | $2.14 | 3.74 % |
| Q4 | 2025-02-04 | $1.72 | $1.68 | 2.38 % |
| Q3 | 2024-10-31 | $1.57 | $1.51 | 3.97 % |
Merck & Co (MRK) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-29 | $15.81B | $15.85B | -0.26 % |
| Q1 | 2025-04-24 | $15.53B | $15.30B | 1.50 % |
| Q4 | 2025-02-04 | $15.62B | $15.51B | 0.74 % |
| Q3 | 2024-10-31 | $16.66B | $16.47B | 1.14 % |
PREGUNTAS FRECUENTES
¿Cuándo Merck & Co (NYSE:MRK) publicará los resultados?
Está previsto que Merck & Co (MRK) presente resultados el octubre 30, 2025. Los últimos resultados se publicaron el julio 29, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Merck & Co (NYSE:MRK)?
El BPA real fue de $2.13, que superó la estimación de $2.01.
¿Cuáles fueron los ingresos de Merck & Co (NYSE:MRK)?
Los ingresos reales fueron $15.8B, que no alcanzó la estimación de $15.8B.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.